Continued cannabis use and outcome in first-episode psychosis: Data from a randomized, open-label, controlled trial

Journal of Clinical Psychiatry

Volumn 73, Issue 5, 2012, Pages 632-638

  Faber, Gunnar ^a   Smid, Henderikus G O M ^b   Van Gool, Arthur R ^a   Wunderink, Lex ^c   Van Den Bosch, Robert J ^b   Wiersma, Durk ^b  

^a Yulius Mental Health Institute   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c GGZ Foundation for Mental Health Care Friesland   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANNABIS ADDICTION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG ABUSE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; REMISSION; RESIDENTIAL CARE; SOCIAL INTERACTION;

EID: 84861796547     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m07069     Document Type: Article

References (35)

1. CBS. (Centraal Bureau voor de Statistiek; Dutch Central Bureau of Statistics) http://www.cbs.nl/en-GB/menu/themas/vrije-tijd-cultuur/ publicaties/artikelen/archief/2009/2009-2860-wm1.htm.
2. Moore THM, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370(9584):319-328. doi:10.1016/S0140-6736(07)6162-3 PubMed (Pubitemid 47094993)
3. McGrath J, Welham J, Scott J, et al. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry. 2010;67(5):440-447. doi:10.101/archgenpsychiatry. 2010.6 PubMed
4. Ferdinand RF, Sondeijker F, van der Ende J, et al. Cannabis use predicts future psychotic symptoms, and vice versa. Addiction. 2005;100(5): 612-618. doi:10.1/j.1360-043.205.01070.x PubMed (Pubitemid 40646286)
5. Hides L, Dawe S, Kavanagh DJ, et al. Psychotic symptom and cannabis relapse in recent-onset psychosis: prospective study. Br J Psychiatry. 2006;189:137-143. PubMed doi:10.192/bjp.bp.105.014308
6. Edwards J, Elkins K, Hinton M, et al. Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatr Scand. 2006;114(2):109-117. doi:10.1/j.160-047.206.0783.x PubMed (Pubitemid 44034269)
7. Hinton M, Edwards J, Elkins K, et al. Reductions in cannabis and other illicit substance use between treatment entry and early recovery in patients with first-episode psychosis. Early Interv Psychiatry. 2007; 1(3):259-266. doi:10.1/j.1751-7893.207.035.x
8. Zammit S, Moore THM, Lingford-Hughes A, et al. Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry. 2008;193(5):357-363. doi:10.192/bjp.bp.107.046375 PubMed
9. Shrivastava A, Johnston M, Shah N, et al. Redefining outcome measures in schizophrenia: integrating social and clinical parameters. Curr Opin Psychiatry. 2010;23(2):120-126. doi:10.1097/YCO.0b013e328362e PubMed
10. Andreasen NC, Carpenter WT Jr, Kane JM, et al. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162(3):441-449. doi:10.176/api.ajp.162.3.41 PubMed (Pubitemid 40343909)
11. Wunderink L, Sytema S, Nienhuis FJ, et al. Clinical recovery in first-episode psychosis. Schizophr Bull. 2009;35(2):362-369. doi:10.1093/schbul/sbn143 PubMed
12. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276. PubMed (Pubitemid 18039085)
13. Wiersma D, de Jong A, Kraaijkamp HJM, et al. GSB: De Groningse Sociale Beperkingen schaal, tweede Versie. Een interviewschema voor het beoordelen van beperkingen in het sociale rolfunctioneren. Handleiding en vragenlijsten (incl scoreformulier) (English edition: GSDS-II: The Groningen Social Disabilities Schedule, second version).Groningen, The Netherlands: Afdeling Sociale Psychiatrie, Rijksuniversiteit Groningen; 1990.
14. Wiersma D. Role functioning as a component of quality of life in mental disorders. In: Katschnig H, Freeman H, Sartorius N, eds. Quality of Life in Mental Disorders. 2nd ed. West Sussex, England: John Wiley & Sons; 2005.
15. Wunderink L, Nienhuis FJ, Sytema S, et al. Guided discontinuation versus maintenance treatment in remitted first-episode psychosis: relapse rates and functional outcome. J Clin Psychiatry. 2007;68(5):654-661. doi:10.408/JCP. v68n0502 PubMed (Pubitemid 46841847)
16. World Health Organization. Schedules for Clinical Assessment in Neuropsychiatry, Dutch version. Geneva, Switzerland: World Health Organization; 1992.
17. SPSS. 15.0 for Windows. Chicago, IL: SPSS Inc; 2006.
18. Milev P, Ho B-C, Arndt S, et al. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry. 2005;162(3):495-506. doi:10.176/api.ajp.162.3.495 PubMed (Pubitemid 40343916)
19. Robinson DG, Woerner MG, McMeniman M, et al. Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry. 2004;161(3):473-479. doi:10.176/api.ajp.161.3.473 PubMed (Pubitemid 38326102)
20. Compton MT, Kelley ME, Ramsay CE, et al. Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients. Am J Psychiatry. 2009; 166(11):1251-1257. doi:10.176/api.ajp.209.0903031 PubMed
21. Bossong MG, van Berckel BNM, Boellaard R, et al. Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology. 2009;34(3):759-766. doi:10.1038/np.208.138 PubMed
22. Stokes PRA, Mehta MA, Curran HV, et al. Can recreational doses of THC produce significant dopamine release in the human striatum? Neuroimage. 2009;48(1):186-190. doi:10.1016/j.neuroimage.209.06.029 PubMed
23. Kuepper R, Morrison PD, van Os J, et al. Does dopamine mediate the psychosis-inducing effects of cannabis? a review and integration of findings across disciplines. Schizophr Res. 2010;121(1-3):107-117. doi:10.1016/j.schres. 2010.05.031 PubMed
24. Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res. 2004;72(1):41-51. doi:10.1016/j.schres.204.09.09 PubMed (Pubitemid 39452904)
25. Holthausen EAE, Wiersma D, Cahn W, et al. Predictive value of cognition for different domains of outcome in recent-onset schizophrenia. Psychiatry Res. 2007;149(1-3):71-80. doi:10.1016/j.psychres.205.07.037 PubMed (Pubitemid 46108095)
26. Gonzalez-Blanch C, Perez-Iglesias R, Pardo-Garcia G, et al. Prognostic value of cognitive functioning for global functional recovery in firstepisode schizophrenia. Psychol Medicine. 2010; 40(6):935-944. PubMed doi:10.1017/S032917091267
27. Faber G, Smid HG, Van Gool AR, et al. Neurocognition and recovery in first episode psychosis. Psychiatry Res. 2011;188(1):1-6. PubMed
28. McPhillips MA, Kelly FJ, Barnes TRE, et al. Detecting comorbid substance misuse among people with schizophrenia in the community: a study comparing the results of questionnaires with analysis of hair and urine. Schizophr Res. 1997;25(2):141-148. doi:10.1016/S0920-964(97)015-7 PubMed (Pubitemid 27245136)
29. Wolford GL, Rosenberg SD, Drake RE, et al. Evaluation of methods for detecting substance use disorder in persons with severe mental illness. Psychol Addict Behav. 1999;13(4):313-326. doi:10.1037/0893-164X.13.4.313
30. Selten JP, Bosman IJ, de Boer D, et al. Hair analysis for cannabinoids and amphetamines in a psychosis incidence study. Eur Neuropsychopharmacol. 2002;12(1):27-30. doi:10.1016/S0924-97X(01)0129-8 PubMed
31. Perkins DO, Gu H, Boteva K, et al. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. Am J Psychiatry. 2005;162(10):1785-1804. doi:10.176/api.ajp.162.10.1785 PubMed (Pubitemid 41428609)
32. Marshall M, Lewis S, Lockwood A, et al. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry. 2005;62(9):975-983. doi:10.101/archpsyc. 62.9.975 PubMed (Pubitemid 41248376)
33. Henquet C, van Os J, Kuepper R, et al. Psychosis reactivity to cannabis use in daily life: an experience sampling study. Br J Psychiatry. 2010; 196(6):447-453. doi:10.192/bjp.bp.109.07249 PubMed
34. Kavanagh DJ, Young R, White A, et al. A brief motivational intervention for substance misuse in recent-onset psychosis. Drug Alcohol Rev. 2004; 23(2):151-155. doi:10.1080/095952304101704127 PubMed (Pubitemid 38907018)
35. Barrowclough C, Haddock G, Wykes T, et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ. 2010; 341(3):c6325. doi:10.136/bmj.c6325 PubMed